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Abstract
Each year, thousands of people worldwide succumb to end-organ failure while awaiting 
life-saving transplantation procedures. The shortage of organs continues with no signs of 
easing in the foreseeable future. The availability of organs from living donors continues to be 
constrained. At the same time, the cumulative knowledge of organ preservation is advancing 
steadily resulting in an enhanced ability to utilize a growing number of previously unsuit-
able tissue and organ gifts. Our ability to procure and preserve more organs is accompanied 
by the increasing use of so-called “expanded criteria” donors, or those whose organs may 
not have been suitable without modern advances in organ preservation science. Within the 
overall context of organ donation from non-living donors, the importance of physiologic and 
end-organ optimization cannot be understated. This chapter discusses our current state of 
understanding of optimized organ procurement approaches derived from practical experi-
ences and “lessons learned” at a high-performing, community-based tertiary referral hospital.
Keywords: clinical optimization, ethical considerations, organ donation, organ 
procurement, organ procurement organization, transplantation
1. Introduction
The process of organ procurement from non-living donors (OPNLD) is multi-factorial and 
complex [1]. In the United States, significant progress has been made toward wider availability 
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of organs for transplantation [2, 3]. This includes increased use of organs from donors after 
cardiac death (DCD) as well as the inclusion of “expanded criteria” donors (ECD) and the 
introduction of information technology-based tools for better organ allocation [3]. Despite 
tremendous progress, major challenges remain including the growing number of patients 
entering transplant waiting lists [4].
It has long been known that more organs may be available than are being currently captured 
within the existing organ procurement organization (OPO) network [5]. In addition, some 
organs are lost through suboptimal organ donor resuscitation and/or lack of timely OPO noti-
fication [6, 7]. In this chapter, the authors will discuss the modern process of OPNLD, begin-
ning with potential donor identification, then proceeding with physiological optimization, 
and finally ending with the procurement procedure. To illustrate key points more effectively, 
a realistic hypothetical case-based scenario will be presented.
2. Case vignette
A 65-year-old male presents via aeromedical flight after a head-on, two-car collision in which 
he was the restrained passenger. The crash occurred at 7:45 pm–approximately 45 min prior 
to his arrival at the regional Trauma Center. The patient’s wife, the driver, was pronounced 
dead at the scene. According to the Emergency Medical Services (EMS) report, the patient had 
Glasgow Coma Scale (GCS) of 9 shortly after the incident and was complaining of left-sided 
chest pain. It took 30 min to extract the patient from the car.
The patient arrived at the regional Trauma Center at 8:32 pm. On initial assessment, blood 
pressure was 90/65 mmHg, pulse was 120 beats/min, respiratory rate was 28 breaths/min 
and the patient had a GCS of 4. Intravenous fluid administration was started and the patient 
was immediately tracheally intubated. The FAST ultrasound exam was negative. Chest radio-
graph showed multiple rib fractures and a pneumothorax on the left, for which a chest tube 
was placed. The secondary trauma survey showed an obvious deformity of the left parietal 
skull, a left chest wall injury, and a visibly displaced left-sided hip fracture.
Hypertonic saline infusion was begun for treatment of a presumed severe traumatic brain 
injury (TBI). Detailed timeline of subsequent events now follows:
• 9:00 pm: Once the patient was hemodynamically stabilized, he was taken for computed 
tomography (CT) of the head, cervical spine, chest, abdomen and pelvis. Immediate review 
of imaging confirmed left hip fracture-dislocation, multiple left-sided rib fractures and a 
pneumothorax on the left. Of special concern was the presence of large left epidural and 
subdural hematomas with evidence of diffuse axonal injury, as well as extensive subarach-
noid hemorrhage. The patient was found to have 1.5 cm midline shift with uncal herniation.
• 9:15 pm: Emergent neurosurgery consultation was placed, with immediate arrival of the 
on-call neurosurgeon. The patient experienced a brief period of hemodynamic instability 
featuring both bradycardia and tachycardia, followed by the appearance of severe hyper-
tension (systolic blood pressures >200 mmHg), and finally the appearance of bilaterally 
dilated, unresponsive pupillary exam. The injury was deemed non-survivable.
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• 9:25 pm: The patient’s neurological exam was consistent with brain death, as confirmed by 
two independent physicians credentialed in this clinical area of expertise. Confirmatory 
testing in the form of cerebral perfusion study was ordered and the patient was taken to the 
intensive care unit (ICU) in the interim for ongoing medical management. In accordance 
with applicable State Laws, The Local Organ Procurement Organization (OPO) was con-
tacted for possible organ donation.
• 10:30 pm: The patient’s family arrived at the hospital and discussed prognosis and goals 
of care with the clinical team. At that time, his family members indicated understanding 
of the diagnosis, and the gravity and irreversibility of his condition. They informed staff 
that the patient was an organ donor and that they would like to honor his wishes in the 
event of brain death. Medical management and stabilization continued in anticipation of 
the cerebral perfusion study.
Figure 1. An example of a Tc-99 m radionuclide cerebral blood flow study showing typical appearance of “no flow” 
within the cranial vault (e.g., the white appearance). At the same time, the facial region is richly perfused with blood 
(e.g., the “hot-nose” sign), providing a stark comparison to the lack of intracranial flow. Credit: Jason Robert Young, 
M.D. Image used under Creative Commons Attribution-Share Alike 4.0 International license.
The Process of Organ Donation from Non-Living Donors: A Case-Based Journey from Potential…
http://dx.doi.org/10.5772/intechopen.76078
71
• 8:30 am: After stabilizing the patient sufficiently for transfer to the radiology department 
for confirmatory brain flow study, determination was made to proceed with such testing 
(Figure 1). Following the confirmatory study to determine brain death, the patient contin-
ued to receive maximum medical management to ensure adequate organ perfusion and 
maintain tissue oxygenation. Representatives of the local OPO were introduced to the fam-
ily and the formal process of organ donation was initiated.
• 9:00 am: All required procedures for determining blood type and tissue match were pro-
gressing as planned. Organ placement discussions between the local OPO and potential 
receiving institutions were ongoing. The patient underwent trans-esophageal echocardiog-
raphy and bronchoscopy to determine his suitability as a heart and lung donor, respec-
tively. Throughout this process, medical optimization of end-organ perfusion continued, 
including the use of advanced cardiac monitoring, as well as intermittent use of vasopres-
sors and inotropes.
• 11:00 am: After determining that the patient will be able to donate his kidneys, pancreas, 
and liver. However, due to severe chest trauma his lungs and heart were not suitable for 
transplantation. At this time, final placement decisions were made.
• 12:00 pm: The patient’s family members were allowed to see him prior to the organ procure-
ment operation. The process was to occur within the next several hours, and was predicated 
on finding a suitable recipient for one of the kidneys. Medical optimization therapy continued.
• 15:30 pm: The patient was taken to the Operating Room for the procurement of bilateral 
kidneys, pancreas and liver. Three different institutions received kidney, liver and combined 
kidney-pancreas for transplantation, respectively. Recipients of the above organs underwent 
uneventful immediate post-transplantation recovery and were able to resume normal lives.
3. Historical background
Organ transplantation and procurement has a rich history, with early accounts of tissue 
removal and re-implantation involving skin, bone and teeth [8]. During the past several 
decades, significant progress was made in the area of human transplantation. The evolu-
tion of both surgical techniques and immunosuppression resulted in organ transplantation 
becoming commonplace [9, 10]. Notable medical pioneers of modern transplantation include 
Dr Christiaan Barnard, Dr Alexis Carrel, Dr Joseph Murray, Dr Thomas Starzl and many oth-
ers who helped advance the basic scientific and medical understanding required to achieve 
today’s state of knowledge and clinical reliability [11, 12].
From a clinical perspective, the first successful transplants of the modern era involved skin 
and corneal tissues, and took place in the early 1900s [8]. These experiences, especially involv-
ing skin grafting, were plagued by failures well before the concept of tissue compatibility and 
rejection was fully elucidated [11]. Solid organ transplantation beginning with the kidney was 
even more challenging. Russian surgeon, Dr Yuri Voronov is credited with the first recorded 
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report of a kidney transplant from a recently deceased donor in the mid-1930s [8, 13, 14]. 
Although unsuccessful, this procedure foreshadowed the various technical and ethical chal-
lenges modern transplantation would face well into the future.
The subsequent years and decades were characterized by a mixture of “trial and error” until 
the first successful living donor kidney transplant was performed in the mid-1950s by Nobel 
prize winner, Dr Joseph Murray [8, 11, 13]. The procedure was performed between identical 
twin brothers, both of whom survived for some time after [15]. Although the understand-
ing of the organ rejection process was still very poor, Murray’s successful transplantation 
strongly implied the need of genetic congruity between donor and recipient. Shortly thereaf-
ter, Main and Prehn discovered that chimerism could be induced by using radiation to weaken 
the immune system of mice, leading to improved acceptance of donor tissue [16, 17]. Several 
years later, Dr Murray attempted this method in his next successful kidney transplantation, 
but this was unfortunately preceded by significant mortality among patients who underwent 
total body irradiation prior to receiving new organs [11, 18]. Of note, this successful non-twin-
twin transplant recipient was the first well-documented case to recover from rejection [11, 19]. 
Subsequent failures associated with total body irradiation, including significant morbidity and 
mortality, led to increased interest in other potential methods of immunosuppression [13].
As a result of intensive research efforts, immunosuppressive medications were soon intro-
duced to help address the problem of graft rejection [20, 21]. Initially the use of monother-
apy was attempted with limited effectiveness. It was Dr Thomas Starzl (whose success rates 
exceeded most in the field at the time) who proposed a cocktail of immunosuppressive agents 
capable of reversing rejection [11]. This was yet another critical discovery that over time facili-
tated the expansion of efforts into transplantation of other solid organs, including the first liver 
transplant in 1963 by Dr Starzl, the pancreas in 1966 by Dr Lillehei and the heart in 1967 by Dr 
Barnard [8, 22–24]. Although long-term survival of early transplants and their recipients var-
ied, the 1960s ushered in a new era with transplant centers appearing across the world [8, 11, 
24]. Organ preservation science developed out of the necessity to ensure organ viability during 
transport from donor to recipient [25].
Beginning in the early 1900s, Charles Guthrie proposed that cooling of organs may offer a 
way to preserve them during transport [11]. It was not until the mid-1960s that the use of 
cooling agents became standard practice with the introduction of the now widely accepted 
University of Wisconsin solution [11, 26, 27]. With progress being made in multiple aspects of 
transplantation, new hope arose for patients suffering from various forms of end-stage organ 
failure. As organ preservation and technical aspects of transplantation advanced, attention 
shifted to ensuring adequate organ availability [7]. Along with this challenge came the ethical 
and legal considerations surrounding death and organ donation, which will be addressed in 
greater detail later on in this chapter.
4. Ethical considerations
It is the responsibility of physicians to “above all, do no harm” [28]. This concept should per-
meate each clinical decision made. In theory, this ethical principle is paramount to an equitable 
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and just system of medicine, but oftentimes physicians find themselves in situations where 
they must weigh the risks and benefits of treatment, and answers are far from apparent [29–32]. 
The field of transplantation is among the most complex medical settings to navigate from 
the ethics standpoint. This is even more evident with the emergence of extremity and face 
transplants [33–35].
As Dr Murray embarked on the first living donor transplant, he faced an ethical dilemma. The 
concept of retrieving an organ from a perfectly healthy individual for implantation in another 
patient was, and still is, a gray area considering that by removing an organ from a perfectly 
healthy donor, you are exposing them to a number of risks. [36]. At the same time, certain organs 
(e.g., heart and pancreas) can only be procured from deceased donors, which raises a completely 
different set of ethical issues. These include questions of donor and recipient eligibility, fair-
ness, procurement procedures, the legal definition of death, donor designation versus family 
permission and compensation [7, 36]. There is also a major concern regarding the potential of 
inequitable allocation of organs [36, 37]. This dilemma gained international attention with the 
first successful cardiac transplant in 1967 by Dr Barnard [38]. The concept of taking a still beating 
heart from someone considered “dead” created a significant conceptual and ethical problem 
in the eyes of many, with calls for a more concrete definition or list of objective criteria includ-
ing non-responsiveness and other neurological signs that defined irreversible coma [8, 36]. 
It would be another 10 years before the Presidential Commission of the Study of the Ethics 
in Medicine proposed the current legal definition of death which included “irreversible ces-
sation of circulatory and respiratory function” or “irreversible cessation of brain function 
including brainstem function” [36, 39]. The concepts of brain death and circulatory death will 
be discussed in greater detail later in this chapter.
Over 33,000 organ transplants were performed in the US in 2016, representing a 20% increase in 
donations over the past 5 years [40]. Yet about 115,000 individuals are currently on the waitlist for 
organ donation and 7000 waitlist candidates died in 2016, while awaiting a life-saving transplan-
tation [40]. Although significant strides were made with regard to increasing donations, there 
continues to be an organ shortage, which has led to some ethically questionable practices [35, 41]. 
The National Organ Transplant Act of 1984 brought together top content experts and outlined 
key issues related to the different aspects of the organ procurement process [42–44]. This group 
established key ethical principles, including the requirement that there would be no payment in 
exchange for organs and that organs must be voluntarily given [36, 43, 44]. This act also estab-
lished our current U.S. system of organ allocation [45]. As one can see, there are numerous ethical 
concerns to take into account from a purely systematic viewpoint. This does not even account 
for the sensitivity of broaching the topic of organ donation to a grieving family coming to grips 
with the loss of a loved one. Even with efforts to encourage individuals to make these end-of-life 
decisions early on through donor registries, it is still common practice in many states to consult 
the family prior to proceeding with the organ procurement process [7]. Because the primary 
focus of this chapter is to describe the organ donation process in non-living donors, we will not 
be discussing numerous other ethical issues that arise when taking into account living donors. 
The subsequent sections of this chapter will outline OPO’s and their critical role in the donation 
process. We will then proceed to describe the organ donation process in the context of both the 
above ethical and historical considerations, as well as the vignette presented earlier in the text.
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5. Organ procurement organizations
The organ procurement process begins with the identification of a potential organ donor, then 
proceeds through the stages of notification of next of kin, the decision to donate, the process of 
physiologic donor optimization, the process of organ procurement and finally the transplan-
tation of donated organs. Throughout this entire sequence of events, the OPO plays a central 
and an integral role [7]. The evolution of OPOs stems from the increased demand for organ 
donation, the need to organize and prioritize the process, and the necessity to ensure that 
organ allocation is performed in a fair and impartial fashion while at the same time efficiently 
and effectively providing organs to those in need [8, 46].
Prior to the inception of the modern network of OPOs, the organ procurement and alloca-
tion process was the responsibility of individual transplant centers [8]. They also shouldered 
the costs of the procurement and transportation process. As one can imagine this created a 
fragmented system in which each center would instinctively focus on providing resources to 
those in need of organs within their own hospital or locality [47, 48]. The evolution of OPO’s 
provided a structured, equitable solution to streamline the process from organ donation to 
transplantation [7]. The current scope of functions of OPOs is vast and diverse, including 
interfacing with patient families; providing support to grieving relatives while helping them 
make critical decisions concerning organ donation; working in conjunction with hospitals and 
health care practitioners to physiologically optimize donors prior to organ procurement; coor-
dinating with the United Network for Organ Sharing (UNOS) to find proper donor matches; 
and facilitating professional and public education as well as related research [7, 49].
6. The process of organ procurement
From the time of identification of potential donor to successful procurement and transplant, 
the process of organ procurement is a complex and intricate undertaking that we will discuss 
in greater detail in this section. For the purposes of our discussion, we will direct our attention 
to donation after death since the subject of live donors is outlined in other chapters. A simpli-
fied schematic of the overall process is shown in Figure 2.
The initial step in donation is centered on the potential organ donor. Although each clinical 
situation is uniquely different, the first step in the process is the recognition of the irreversible 
process of brain death, or the circumstances leading to non-heart beating donation [7, 50]. 
When examining the topic of donation after cardiac or circulatory death, we must go back to 
the corresponding legal and ethical definitions [23, 51, 52]. How and when does one deter-
mine brain death and circulatory death? In the current chapter’s vignette, the circumstances of 
brain death were unequivocal as the patient had suffered a non-survivable injury. We realize 
that in clinical practice it may not be this straightforward, and repeated exams or confirma-
tory testing may provide the family with a greater degree of certainty regarding the finality 
of this devastating diagnosis. More specifically, confirmatory brain death determination with 
the brain scan showing “no blood flow” to the brain was helpful in the current scenario.
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Another critically important consideration is the emotional state of a family coming to grips 
with the untimely and unexpected loss of a loved one. The grief combined with the immense 
responsibility of determining what a loved one “may have wanted” can place a significant 
burden on his or her relatives. This can be especially difficult for families of patients with no 
advance directive, living will, power of attorney, or prior conversation concerning their organ 
donation wishes. When dealing with issues related to organ donation, health care providers 
must be extremely sensitive to family needs and ensure that their local OPO is involved early 
on in the process in order to prevent any potential conflict of interest [7]. The separation of 
responsibilities during these proceedings is critical in alleviating any concerns regarding the 
simultaneous provision of care for the patient along with facilitation of the organ donation 
process by the same individual and/or team [53, 54].
From the time a potential donor arrives to the hospital and is determined to have non-surviv-
able injury, it is important that they are managed under the assumption that they may donate 
organs, and that care is both optimal and timely [6, 55, 56]. This includes early notification of 
the local OPO regarding the presence of a potential donor [7]. A great deal of attention must be 
paid to prevent hypoxia and systemic hypo-perfusion, both of which could compromise the 
Figure 2. Simplified schematic of the organ donation process. Following the identification of potential organ donor, a 
cascade of events takes place that ultimately ends with successful organ transplantation. Further details regarding this 
complex process can be obtained from Wojda et al. [7].
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viability of the donor’s organs [56, 57]. As was the case in our hypothetical vignette, the patient 
should be stable before undergoing any confirmatory testing. In the current example, such sta-
bilization required approximately 10–12 h of continuous effort by the critical care team. Once 
the decision is made to donate by the family in the case of brain death or circulatory death, 
the OPO helps coordinate the remainder of the care process, including the distribution of the 
organs and the provision of highly trained staff to prepare for the actual organ procurement 
and preservation, as well as highly efficient transport of preserved organs to each recipient’s 
institution [7]. At this time, we will discuss key components of the process of organ donation, 
including the determination of death and physiologic optimization of the donor.
7. Determination of death
As discussed earlier in the chapter, declaration of death—whether that be circulatory death 
or brain death—has been a controversial topic over the years. In 2014, an international forum 
was held in Montreal, Canada with the objective to provide a functional definition of death 
that encompassed the concepts of brain and circulatory death. They reported that “Death is 
the permanent loss of capacity for consciousness and all brainstem functions. This may result 
from permanent cessation of circulation or catastrophic brain injury. In the context of death 
determination, ‘permanent’ refers to loss of function that cannot resume spontaneously and 
will not be restored through intervention” [58]. It is important for health care practitioners of 
all levels working with potential donor patients to have a good understanding of the defini-
tion of death in order to be able to explain to grieving families the reality of the situation and 
its finality [59]. It is well established that adequate explanation of brain death is one of the 
critical components of the donation process [60]. The optimal timing of the consent process is 
also of great importance [61]. Checklists are helpful in maintaining the thoroughness of brain 
death determination, but do not replace the expertise, knowledge and compassion of physi-
cians in end-of-life discussions with families of the potential donor.
8. Brain death determination
When a patient presents to the hospital with concern for altered consciousness, it is impera-
tive to rule out all reversible causes of coma, first excluding the presence of any substances 
of abuse, medication side effects, electrolyte, metabolic or acid-base derangements [62]. Once 
these are ruled out, imaging can often shed some light on potential causes of neurological 
compromise. In the current case vignette, the CT was utilized in order to give the treating 
physician an indication of the magnitude of injury and likelihood of recovery. With that being 
said, official declaration of BD is actually a clinical one [63]. From definitional standpoint, 
BD is considered to be present when there is irreversible damage to the brain and brainstem 
[36]. In order to assess brain function, several key components are required, with the most 
important one being a thorough neurological examination including assessment of brainstem 
reflexes [62]. Various ancillary tests can also be performed to assess cerebral blood flow and 
brain electrical activity in cases with equivocal exam findings. The final declaration of BD 
(including the official time of death) rests with the treating physician.
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Determination of brain death (BD) can be a complex issue in the evaluation of catastrophic 
neurological injury. Clinical diagnosis of BD is relatively uncommon in the acute care setting. 
Usually acute injury does not progress to the degree of absent brainstem reflexes and apnea. 
“The small percentage of…cases may be related to many factors including early aggressive 
care like decompressive craniectomies, change in referral patterns, and early withdrawal of 
care or decision to proceed with a donation after cardiac death protocol” [64]. There are pre-
defined criteria for the clinical determination of BD which may vary slightly from country to 
country. The neurological assessment of suspected BD typically requires at least 25 tests and 
verifications. “The overriding principle is simple: establish cause, exclude confounders, deter-
mine futility of interventions, examine brainstem reflexes and test for apnea” [64].
Due to frequent inconsistencies related to the determination of BD, the Quality Standards 
Subcommittee of the American Academy of Neurology (AAN) met in the 1990s to establish 
clear definitions of clinical terms and associated testing. The group also determined the validity 
of ancillary testing versus the clinical exam and its applicability to the organ donation process. 
Clinical criteria for BD require a formal assessment and are only undertaken once all other 
potentially reversible cause are excluded. The initial evaluation needs to ensure there are “no 
lingering effects of prior sedation, or prior use of illegal drugs or alcohol. A reasonable guide-
line is to calculate 5–7 times the drug’s elimination half-life in hours and allow that time to pass 
before clinical exam is performed” [64]. A core temperature of 36°C is also recommended which 
can be aided by use of warming blankets if necessary. As in the current chapter’s vignette, 
neuroimaging such as a CT scan of the head should be performed to help determine cause of 
mental status deterioration. Clinical examination must include a thorough neurological exami-
nation including assessment of patient’s level consciousness, as well as evaluation for verbal 
and motor deficits. The above exam must also include the interrogation of brainstem reflexes 
including pupillary, corneal, pharyngeal, and tracheal responses, as well as oculocephalic 
reflexes with doll’s eye and cold caloric assessments. Apnea testing requires documentation of 
absence of a respiratory drive after a CO
2
 challenge. This methodology also has strict criteria 
that must be followed to ensure accurate determination of absent respiratory drive [65, 66].
Although ancillary testing, such as electroencephalography (EEG), cerebral angiography, 
nuclear flow scan, transcranial Doppler, CT angiography and magnetic resonance (MR) angi-
ography, can be utilized in the process of determining BD—due to variability in the interpre-
tation of these studies—it is not a substitute for the clinical examination [67–70]. In aggregate, 
the above tests can provide additional data on electrical brain function and cerebral blood 
flow and “…can be used when uncertainty exist about the reliability of parts of the neuro-
logical examination or when the apnea test cannot be performed” [71, 72]. Expertise in deter-
mining brain death can be inadequate due to multitude of factors, including lack of clinical 
experience. This is likely one of the reasons why 6 US states require confirmation by a second 
examiner and some specifically require at least one of these examiners to be either a neurolo-
gist, neurosurgeon or intensivist [73].
As one can see, the determination of brain death can be quite complex in and of itself and can 
be even further complicated when the question of organ donation is raised. This is why we 
stress the importance of early involvement of a local OPO [73]. After the declaration of BD, 
assuming the presence of consent for organ and tissue donation, the care of the donor shifts to 
optimizing organ perfusion and viability [7]. The preservation of organs after determination 
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of BD also requires excellent coordination between the OPO and the medical management 
team [7, 64]. The key concerns for the medical team are to ensure hemodynamic stability and 
avoid the development of hyper/hypo-glycemia, acid-base or electrolyte derangements and 
pulmonary edema [7]. Many diagnostic tests and interventions occur during this phase spe-
cifically to ensure viability of key body systems and organs. Accumulated clinical evidence 
suggests “that a delay in declaration of brain death not only prolongs the time to organ recov-
ery but also may increase the risks to transplantable organs, resulting in more complicated 
post-operative phases for the recipient” [64]. Finally, there is also evidence suggesting that 
second BD examination may negatively affect organ donor physiology due to inherent time 
delays [74], thus lending indirect support for ancillary/confirmatory BD testing.
From historical perspective, transplantation of organs was premised on the so-called “dead 
donor rule”, where donors must be declared dead according to established medical and legal 
criteria prior to donation [75]. According to Chaten [76], “the dead donor rule (DDR) maintains 
that it is illicit to procure vital organs from donors until after they have been declared dead”. 
This rule also required adherence to strict BD criteria, directly referencing that the “dead 
donor rule mandates simultaneous life and death within the same body for organ donation, 
a biological status that is inherently contradictory” [76]. The best way to decrease variability 
in BD determination is for all hospitals to implement the established set of AAN brain death 
guidelines [71, 77]. This would lead to less confusion and fewer inconsistencies among institu-
tions. Due to the many complexities of end-of-life discussions, it is imperative that BD deter-
mination protocols become increasingly uniform in both content and application. Wahlster 
et al. [78] looked at practices and perceptions regarding BD declaration in 91 countries, not-
ing that “countries with an organized transplant network were more likely to have a brain 
death provision compared with countries without” [78]. Barriers to consensus on universal BD 
standardization include social, religious and economic factors specific to each country and/or 
culture. Wahlster et al. [78] further note that “future efforts for uniform policies will need to 
include physicians with neurologic and critical care expertise, representatives of national and 
international major medical organizations such as the World Health Organization or World 
Federation of Neurology, and scientific and medical advisors of government agencies” [76].
9. Circulatory death determination
The shortage of organ donors has prompted resurgence in the utilization of donation after 
circulatory or cardiac death (DCD) [23, 51, 79]. While the concept of BD has been extensively 
discussed and there is a reasonable consensus as far as applicable criteria and assessments are 
concerned, definitive guidelines with respect to DCD continue to pose a challenge. In 1993, 
the Pittsburg non-beating heart organ donation protocol was proposed in order to provide 
criterion for organ procurement in the case of circulatory death. This protocol has come under 
criticism due to its questionable ethical application [80]. Although a definitive consensus is 
yet to be made from a legal and ethical standpoint, various OPOs are performing organ pro-
curements with their own sets of standards and protocols [80]. Of interest, DCD historically 
constituted the largest proportion of organ donations prior to the advent of donation after BD. 
Subsequently, its utilization decreased substantially due to superior graft survival outcomes 
following donation after BD [81, 82].
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10. Physiological optimization of the organ donor
Throughout the process of organ procurement, it is critical to achieve physiologic normalization 
and maintain systemic homeostasis in order to optimize the number of organs procured from each 
donor [6, 7, 83]. With this in mind, it is essential that potential donors be attentively managed in 
order to prevent systemic hypoxia and hypoperfusion to vital organs [7]. As in the current chapter’s 
vignette, the ICU is the ideal location for the resuscitation of organ donors and the associated com-
plex physiological and management needs [56, 84]. Cessation of brain function sets off a myriad of 
multi-system manifestations (e.g. cardiac arrhythmia, hypotension, profound acid-base and elec-
trolyte imbalances) many of which can result in subsequent end-organ insufficiency and/or failure 
[56]. Consequently, ICU teams must be cognizant of these considerations and proactively work 
to counteract deleterious effects of BD through a number of intensive interventions. Adherence 
to strict protocols for management of the organ donor is of utmost importance to ensure optimal 
conversion rates and graft survival among recipients [7, 84]. Because such protocols may differ 
from center to center, it is essential for ICU teams to work with local OPOs to ensure standardiza-
tion in the approach taken to optimize the organ donor prior to the procurement procedure [7, 84]. 
This alliance can help standardize the care received by each patient, regardless of the institution, 
and also provide important feedback on what is working and what may not be working. This then 
helps facilitate performance improvement from an OPO system standpoint [7].
As previously mentioned, there are multiple adverse physiologic events that may occur when 
the brain ceases to function (Figure 3). These include reflexive hypertension and subsequent 
hypotension; systemic “endocrine failure” leading to significant hormonal derangements includ-
ing diabetes insipidus; and finally secondary phenomena such as acute lung injury and neuro-
genic pulmonary edema [85–88]. When managing patients, who succumbed to BD following TBI 
and multi-system trauma, special care must be dedicated to preventing any secondary insults 
Figure 3. A diagram showing the most important and most commonly reported systemic manifestations following 
brain death. In the management of an organ donor consideration must be made to all of the above changes, including 
proactive approaches to normalize any deleterious physiologic disturbances.
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from any injury that may pose a potential threat to end-organ viability [87, 89–91]. In order to 
properly monitor the various changes that may be rapidly occurring within the donor, frequent 
laboratory assessments and advanced cardiopulmonary monitoring are recommended [7, 57, 62, 
92]. Correcting electrolyte and metabolic abnormalities can increase viability of donated organs 
according to an observational study conducted by UNOS [92]. Another important UNOS report 
stated that by setting certain parameters or goals for managing donors during the period leading 
up to organ procurement, care teams were able to augment the number of viable organs from 
each donor [83]. Among endpoints that increased likelihood of organ viability were maintenance 
of central venous pressure as well as PaO
2
:FiO
2
 ratio, optimization of cardiac ejection fraction and 
normalization of serum sodium and creatinine [83]. Thyroid hormone levels are another impor-
tant element to closely monitor and correct during organ optimization. Exogenous thyroid hor-
mone is routinely administered along with methylprednisolone and insulin to maximize organ 
donor viability [62, 83, 92]. Among more progressive developments, the use of extracorporeal 
membrane oxygenation has been proposed as a method for expanding the donor pool after car-
diac death [93]. However, this approach may be prohibitive from a financial standpoint.
11. Conclusion
In summary, the field of transplantation has made significant strides throughout the years. 
Following its humble beginnings as an experimental science, it evolved into the primary ther-
apeutic option for patients suffering from end-stage-organ failure. Modern transplantation 
offers hope to those who even a few decades ago would have none. Going hand-in-hand with 
that hope are the ethical and legal ramifications related to the donor and their families. With 
the demand for organs far exceeding the current availability, a better framework is needed 
for both maximizing the procurement of organs from eligible donors and better allocation of 
these gifts-of-life across patients on transplant waiting lists. Closer examination of all avail-
able organ donation avenues is warranted, including the assessment of opportunities offered 
by the use of expanded criteria donors and greater utilization of donation after cardiac death.
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